Literature DB >> 24472834

How I treat isolated distal deep vein thrombosis (IDDVT).

Gualtiero Palareti1.   

Abstract

Thromboses limited to infrapopliteal leg deep veins (isolated distal deep vein thrombosis [IDDVT]) are frequently diagnosed in subjects with suspected pulmonary embolism or DVT and account for one-fourth to one-half of all diagnosed leg DVTs. Despite their frequency, the natural history of IDDVTs and their real risk of thromboembolic complications are still uncertain because of the scarcity of prospective, blind, nonintervention studies. Therefore it is still debated whether they warrant diagnosis and treatment. Diagnosis is based on ultrasonographic examination, which is more operator dependent and less sensitive in distal than in proximal veins. The available data seem to support the view that most IDDVTs are self-limiting and inconsequential for patients, though in some cases they can be associated with complications and warrant diagnosis and treatment. The available guidelines for treatment of IDDVTs give different indications ranging from serial imaging of the deep veins for 2 weeks to detect and treat only in case of proximal extension, to giving oral anticoagulation in all IDDVT patients for 3 months. I review this issue, focusing on possible and suggested treatments in symptomatic IDDVT patients, and describe our current therapeutic approach to these patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24472834     DOI: 10.1182/blood-2013-10-512616

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Do isolated calf deep vein thrombosis need anticoagulant treatment?

Authors:  Gualtiero Palareti
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Risk factors for venous thromboembolism in patients undergoing craniotomy for neoplastic disease.

Authors:  Kristopher T Kimmell; Kevin A Walter
Journal:  J Neurooncol       Date:  2014-08-23       Impact factor: 4.130

3.  Reasons for the persistent incidence of venous thromboembolism.

Authors:  John A Heit; Aneel Ashrani; Daniel J Crusan; Robert D McBane; Tanya M Petterson; Kent R Bailey
Journal:  Thromb Haemost       Date:  2016-12-15       Impact factor: 5.249

4.  Bevacizumab Plus Direct Oral Anticoagulant Therapy in Ovarian Cancer Patients with Distal Deep Vein Thrombosis.

Authors:  Shinichi Komiyama; Masaru Nagashima; Tomoko Taniguchi; Takayuki Rikitake; Mineto Morita
Journal:  Clin Drug Investig       Date:  2019-04       Impact factor: 2.859

5.  3rd Guideline for Perioperative Cardiovascular Evaluation of the Brazilian Society of Cardiology.

Authors:  Danielle Menosi Gualandro; Pai Ching Yu; Bruno Caramelli; André Coelho Marques; Daniela Calderaro; Luciana Savoy Fornari; Claudio Pinho; Alina Coutinho Rodrigues Feitosa; Carisi Anne Polanczyk; Carlos Eduardo Rochitte; Carlos Jardim; Carolina L Z Vieira; Debora Y M Nakamura; Denise Iezzi; Dirk Schreen; Eduardo Leal Adam; Elbio Antonio D'Amico; Emerson Q de Lima; Emmanuel de Almeida Burdmann; Enrique Indalecio Pachón Mateo; Fabiana Goulart Marcondes Braga; Fabio S Machado; Flavio J de Paula; Gabriel Assis Lopes do Carmo; Gilson Soares Feitosa-Filho; Gustavo Faibischew Prado; Heno Ferreira Lopes; João R C Fernandes; José J G de Lima; Luciana Sacilotto; Luciano Ferreira Drager; Luciano Janussi Vacanti; Luis Eduardo Paim Rohde; Luis F L Prada; Luis Henrique Wolff Gowdak; Marcelo Luiz Campos Vieira; Maristela Camargo Monachini; Milena Frota Macatrão-Costa; Milena Ribeiro Paixão; Mucio Tavares de Oliveira; Patricia Cury; Paula R Villaça; Pedro Silvio Farsky; Rinaldo F Siciliano; Roberto Henrique Heinisch; Rogerio Souza; Sandra F M Gualandro; Tarso Augusto Duenhas Accorsi; Wilson Mathias
Journal:  Arq Bras Cardiol       Date:  2017 Jan-Feb       Impact factor: 2.000

6. 

Authors:  André Arpad Faludi; Maria Cristina de Oliveira Izar; José Francisco Kerr Saraiva; Ana Paula Marte Chacra; Henrique Tria Bianco; Abrahão Afiune; Adriana Bertolami; Alexandre C Pereira; Ana Maria Lottenberg; Andrei C Sposito; Antonio Carlos Palandri Chagas; Antonio Casella; Antônio Felipe Simão; Aristóteles Comte de Alencar; Bruno Caramelli; Carlos Costa Magalhães; Carlos Eduardo Negrão; Carlos Eduardo Dos Santos Ferreira; Carlos Scherr; Claudine Maria Alves Feio; Cristiane Kovacs; Daniel Branco de Araújo; Daniel Magnoni; Daniela Calderaro; Danielle Menosi Gualandro; Edgard Pessoa de Mello; Elizabeth Regina Giunco Alexandre; Emília Inoue Sato; Emilio Hideyuki Moriguchi; Fabiana Hanna Rached; Fábio César Dos Santos; Fernando Henpin Yue Cesena; Francisco Antonio Helfenstein Fonseca; Henrique Andrade Rodrigues da Fonseca; Hermes Toros Xavier; Isabela Cardoso Pimentel Mota; Isabela de Carlos Back Giuliano; Jaqueline Scholz Issa; Jayme Diament; João Bosco Pesquero; José Ernesto Dos Santos; José Rocha Faria; José Xavier de Melo; Juliana Tieko Kato; Kerginaldo Paulo Torres; Marcelo Chiara Bertolami; Marcelo Heitor Vieira Assad; Márcio Hiroshi Miname; Marileia Scartezini; Neusa Assumpta Forti; Otávio Rizzi Coelho; Raul Cavalcante Maranhão; Raul Dias Dos Santos; Renato Jorge Alves; Roberta Lara Cassani; Roberto Tadeu Barcellos Betti; Tales de Carvalho; Tânia Leme da Rocha Martinez; Viviane Zorzanelli Rocha Giraldez; Wilson Salgado
Journal:  Arq Bras Cardiol       Date:  2017-07       Impact factor: 2.000

7.  Whose Benchmark Is Right? Validating Venous Thromboembolism Events Between Trauma Registries and Hospital Administrative Databases.

Authors:  Todd A Miano; Grigor Abelian; Mark J Seamon; Kristen Chreiman; Patrick M Reilly; Niels D Martin
Journal:  J Am Coll Surg       Date:  2019-02-15       Impact factor: 6.113

Review 8.  Should we diagnose and treat distal deep vein thrombosis?

Authors:  Helia Robert-Ebadi; Marc Righini
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 9.  Landmark trials in thrombotic vascular disease: a critical appraisal of potential practice-changing trials in 2016-2017.

Authors:  Andrea Cervi; James Demetrios Douketis
Journal:  Intern Emerg Med       Date:  2018-07-27       Impact factor: 3.397

Review 10.  Controversies in venous thromboembolism: the unique case of isolated distal deep vein thrombosis.

Authors:  Angelo Porfidia; Annamaria Carnicelli; Nicola Bonadia; Roberto Pola; Raffaele Landolfi
Journal:  Intern Emerg Med       Date:  2016-04-28       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.